PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-22.90%
Negative revenue growth while Insurance - Life median is -7.20%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-22.90%
Negative gross profit growth while Insurance - Life median is -7.20%. Seth Klarman would suspect poor product pricing or inefficient production.
-43.67%
Negative EBIT growth while Insurance - Life median is -43.51%. Seth Klarman would check if external or internal factors caused the decline.
-43.67%
Negative operating income growth while Insurance - Life median is -43.67%. Seth Klarman would check if structural or cyclical issues are at play.
-49.40%
Negative net income growth while Insurance - Life median is -49.40%. Seth Klarman would investigate factors dragging net income down.
-49.39%
Negative EPS growth while Insurance - Life median is -49.25%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-49.40%
Negative diluted EPS growth while Insurance - Life median is -50.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
89.57%
OCF growth of 89.57% while Insurance - Life is zero. Walter Schloss might see a modest positive difference, which can compound over time.
89.57%
FCF growth of 89.57% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
71.44%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 0.10%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
46.57%
5Y revenue/share growth 1.25-1.5x Insurance - Life median of 32.81%. Mohnish Pabrai might attribute the outperformance to scale or brand strength.
-30.45%
Negative 3Y CAGR while Insurance - Life median is 0.00%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
No Data
No Data available this quarter, please select a different quarter.
338.41%
OCF/share CAGR of 338.41% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
71.16%
3Y OCF/share growth > 1.5x Insurance - Life median of 7.21%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
127.28%
Net income/share CAGR of 127.28% while Insurance - Life median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
29.43%
Net income/share CAGR of 29.43% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that can expand mid-term.
-31.55%
Negative 3Y CAGR while Insurance - Life median is -13.82%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
250.58%
Equity/share CAGR of 250.58% while Insurance - Life median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
152.76%
5Y equity/share CAGR > 1.5x Insurance - Life median of 0.39%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
7.60%
3Y equity/share CAGR of 7.60% while Insurance - Life median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.02%
We expand assets while Insurance - Life is negative. Peter Lynch sees a possible advantage if expansions align with profitable markets or a recovering cycle.
0.55%
BV/share growth of 0.55% while Insurance - Life is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-15.68%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-3.49%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.